Sarah Caulfield
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers 17
- Inflammatory Biomarkers in Disease Prognosis 8
- Cancer Diagnosis and Treatment 4
- Pancreatic and Hepatic Oncology Research 4
-
- Renal cell carcinoma treatment 22
-
- Bladder and Urothelial Cancer Treatments 13
-
- Multiple and Secondary Primary Cancers 6
-
- Economic and Financial Impacts of Cancer 6
- Co-authors
- Mehmet Asım BilenBradley Curtis CarthonÖmer KüçükChristine DavisDylan J. MartiniYuan LiuWayne HarrisJacqueline T. Brown
- Journals
- Journal of Clinical Oncology (14 papers)SHILAP Revista de lepidopterología (3 papers)The Oncologist (7 papers)
- Partner nations
- United StatesUnited KingdomIreland
In The Last Decade
Sarah Caulfield
39 papers receiving 352 citations
Peers
Comparison fields: 5 of 55
- Oncology 235
- Pulmonary and Respiratory Medicine 163
- Cancer Research 36
- Internal Medicine 7
- Immunology 33
Countries citing papers authored by Sarah Caulfield
This map shows the geographic impact of Sarah Caulfield's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sarah Caulfield with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sarah Caulfield more than expected).
Fields of papers citing papers by Sarah Caulfield
This network shows the impact of papers produced by Sarah Caulfield. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sarah Caulfield. The network helps show where Sarah Caulfield may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Sarah Caulfield, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2026 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 1 | |
| 6 | 2022 | 13 | |
| 7 | 2022 | 28 | |
| 8 | 2021 | 5 | |
| 9 | 2021 | 7 | |
| 10 | 2021 | 26 | |
| 11 | 2021 | 4 | |
| 12 | 2021 | 7 | |
| 13 | 2021 | 1 | |
| 14 | 2020 | 8 | |
| 15 | 2020 | 1 | |
| 16 | 2019 | 5 | |
| 17 | 2019 | 48 | |
| 18 | 2018 | 26 | |
| 19 | 2017 | 1 | |
| 20 | 2010 | 5 |
About Sarah Caulfield
Sarah Caulfield is a scholar working on Oncology, Pulmonary and Respiratory Medicine and Surgery, having authored 42 papers that have together received 353 indexed citations. Recurring topics across this work include Renal cell carcinoma treatment (22 papers), Cancer Immunotherapy and Biomarkers (17 papers), Bladder and Urothelial Cancer Treatments (13 papers), Inflammatory Biomarkers in Disease Prognosis (8 papers), Multiple and Secondary Primary Cancers (6 papers), Economic and Financial Impacts of Cancer (6 papers), Cancer Diagnosis and Treatment (4 papers) and Pancreatic and Hepatic Oncology Research (4 papers). The work is most often cited by research in Oncology (235 citations), Pulmonary and Respiratory Medicine (163 citations) and Cancer Research (36 citations). Sarah Caulfield has collaborated with scholars based in United States, United Kingdom and Ireland. Frequent co-authors include Mehmet Asım Bilen, Bradley Curtis Carthon, Ömer Küçük, Christine Davis, Dylan J. Martini, Yuan Liu, Wayne Harris, Jacqueline T. Brown, Viraj A. Master and Bassel Nazha. Their work appears in journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and The Oncologist.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.